Market Overview

UPDATE: Wunderlich Initiates Cardiovascular Systems with Buy on Positive Outlook

Share:
Related CSII
28 Stocks Moving In Monday's Pre-Market Session
Cardiovascular Systems (CSII) Hits 52-Week High on Solid Q3

In a report published Friday, Wunderlich Securities analyst James Terwilliger initiated coverage on Cardiovascular Systems (NASDAQ: CSII) with a Buy rating and $24.00 price target.

In the report, Wunderlich Securities noted, “We are initiating coverage of Cardiovascular Systems, Inc. (CSII) with a Buy rating and a 12-month price target of $24.00, or 4.0x our fiscal 2015 revenue per share estimate of $6.08. CSII is a medical device company focused on minimally invasive treatments for vascular disease. CSII's initial focus is on the treatment of peripheral artery disease (PAD). CSII's products are catheter-based systems capable of treating a range of plaque types in leg arteries both above and below the knee. CSII intends to expand its catheter-based systems and move into the interventional coronary market. CSII has already sent its PMA application to the FDA to treat coronary artery disease. We assume regulatory approval and a coronary product launch in the U.S. in Q114.”

Cardiovascular Systems closed on Thursday at $20.79.

Latest Ratings for CSII

DateFirmActionFromTo
Sep 2017Raymond JamesInitiates Coverage OnMarket Perform
Jun 2017Bank of AmericaDowngradesNeutralUnderperform
Aug 2016Leerink SwannUpgradesMarket PerformOutperform

View More Analyst Ratings for CSII
View the Latest Analyst Ratings

Posted-In: James Terwilliger Wunderlich SecuritiesAnalyst Color Initiation Analyst Ratings

 

Related Articles (CSII)

View Comments and Join the Discussion!

Partner Center